[Insatiable challenge for eradication of leprosy].
Ishibashi
Yasumasa
Y
D000818:Animals; D016207:Cytokines; D006801:Humans; D007113:Immunity, Innate; D018836:Inflammation Mediators; D007918:Leprosy / Q000145:classification / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D008247:Lysosomes / Q000382:microbiology; D008264:Macrophages / Q000166:cytology; D009166:Mycobacterium leprae / Q000235:genetics; D016328:NF-kappa B; D011110:Polymorphism, Genetic; D017434:Protein Structure, Tertiary; D051195:Toll-Like Receptor 2 / Q000235:genetics
D016207:Cytokines; D018836:Inflammation Mediators; D016328:NF-kappa B; C495342:TLR2 protein, human; D051195:Toll-Like Receptor 2